Cargando…
Severe QT interval prolongation associated with moxifloxacin: a case report
INTRODUCTION: The QT interval prolongation is an adverse effect associated with moxifloxacin. This adverse effect can lead to potentially life-threatening arrhythmias such as Torsades de pointes. We describe a case of severe QT interval prolongation associated with moxifloxacin which may cause the d...
Autores principales: | Koide, Tetsuro, Shiba, Masato, Tanaka, Katsuhiro, Muramatsu, Masatoshi, Ishida, Satoshi, Kondo, Yoshihiro, Watanabe, Keiko |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2621134/ https://www.ncbi.nlm.nih.gov/pubmed/19099576 http://dx.doi.org/10.1186/1757-1626-1-409 |
Ejemplares similares
-
Meropenem/moxifloxacin/umifenovir: QT interval prolongation and off label use: 2 case reports
Publicado: (2021) -
Pharmacokinetic-pharmacodynamic analysis to evaluate the effect of moxifloxacin on QT interval prolongation in healthy Korean male subjects
por: Hong, Taegon, et al.
Publicado: (2015) -
Effect of QT interval-prolonging drugs taken in pregnancy on the neonatal QT interval
por: Michel, Holger, et al.
Publicado: (2023) -
Beyond a prolonged QT interval
por: Bitar, Zouheir Ibrahim, et al.
Publicado: (2013) -
Hydroxychloroquine-associated QT interval prolongation
Publicado: (2020)